Johnson & Johnson vs West Pharmaceutical Services, Inc.
JNJ vs WST — side-by-side comparison from reported financials. JNJ leads 8, WST leads 3 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
| Metric | JNJ | WST |
|---|---|---|
| Price | $261.79 | $366.00 |
| Market cap | $631B | $25.8B |
| Revenue (TTM) | $97.9B | $3.33B |
| Revenue growth | +5.6% | +2.1% |
| Net margin | 21.5% | 17.0% |
| Free cash flow | $22.2B | $437M |
| Net cash (debt) | ($27.8B) | $589M |
| 1-year price return | +37.0% | +38.9% |
| P/E | 29.9 | 47.7 |
| P/E vs own history (cheap-side %) | 16% | 39% |
| Dividend yield | 2.00% | 0.23% |
| Return on equity | 26% | 19% |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 140,800 | 10,800 |
Full résumé-style profiles: JNJ CV · WST CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.